[go: up one dir, main page]

LT2968174T - Dviem būdais vartojama geriamoji sulfato druskų tablečių farmacinė kompozicija ir jos naudojimo būdai - Google Patents

Dviem būdais vartojama geriamoji sulfato druskų tablečių farmacinė kompozicija ir jos naudojimo būdai

Info

Publication number
LT2968174T
LT2968174T LTEP14722461.2T LT14722461T LT2968174T LT 2968174 T LT2968174 T LT 2968174T LT 14722461 T LT14722461 T LT 14722461T LT 2968174 T LT2968174 T LT 2968174T
Authority
LT
Lithuania
Prior art keywords
pharmaceutical composition
oral pharmaceutical
sulphate salt
tables
way oral
Prior art date
Application number
LTEP14722461.2T
Other languages
English (en)
Inventor
Edmund V. Dennett Jr.
David S. Wells
Original Assignee
Braintree Laboratories, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Braintree Laboratories, Inc. filed Critical Braintree Laboratories, Inc.
Publication of LT2968174T publication Critical patent/LT2968174T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01D—COMPOUNDS OF ALKALI METALS, i.e. LITHIUM, SODIUM, POTASSIUM, RUBIDIUM, CAESIUM, OR FRANCIUM
    • C01D5/00—Sulfates or sulfites of sodium, potassium or alkali metals in general
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Materials Engineering (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LTEP14722461.2T 2013-03-15 2014-03-14 Dviem būdais vartojama geriamoji sulfato druskų tablečių farmacinė kompozicija ir jos naudojimo būdai LT2968174T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361798759P 2013-03-15 2013-03-15
PCT/US2014/028805 WO2014144407A1 (en) 2013-03-15 2014-03-14 Dual use oral pharmaceutical composition tablets of sulfate saltes and methods of use thereof

Publications (1)

Publication Number Publication Date
LT2968174T true LT2968174T (lt) 2020-01-10

Family

ID=50680164

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14722461.2T LT2968174T (lt) 2013-03-15 2014-03-14 Dviem būdais vartojama geriamoji sulfato druskų tablečių farmacinė kompozicija ir jos naudojimo būdai

Country Status (25)

Country Link
US (2) US9919007B2 (lt)
EP (2) EP3563838A1 (lt)
JP (2) JP6441890B2 (lt)
CN (2) CN105142617B (lt)
AU (3) AU2014227598B2 (lt)
BR (1) BR112015019776A2 (lt)
CA (1) CA2903283C (lt)
CY (1) CY1122387T1 (lt)
DK (1) DK2968174T3 (lt)
EA (2) EA034234B1 (lt)
ES (1) ES2764462T3 (lt)
HK (1) HK1214519A1 (lt)
HR (1) HRP20192227T1 (lt)
HU (1) HUE046754T2 (lt)
IL (1) IL241367A0 (lt)
LT (1) LT2968174T (lt)
ME (1) ME03656B (lt)
MX (1) MX377525B (lt)
PE (1) PE20151543A1 (lt)
PL (1) PL2968174T3 (lt)
PT (1) PT2968174T (lt)
RS (1) RS59667B1 (lt)
SI (1) SI2968174T1 (lt)
SM (1) SMT201900716T1 (lt)
WO (1) WO2014144407A1 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2968174T3 (pl) 2013-03-15 2020-05-18 Braintree Laboratories, Inc. Tabletki doustne kompozycji farmaceutycznej soli siarczanowych o podwójnym zastosowaniu i sposoby ich zastosowania
WO2016040733A1 (en) * 2014-09-12 2016-03-17 Braintree Laboratories, Inc. Sulfate salt solution laxative compositions and methods of use thereof
US11007170B2 (en) 2017-02-02 2021-05-18 Panaxia Pharmaceutical Industries Ltd. Composition for buccal or sublingual administration of cannabis extract and methods for making same
US10143656B1 (en) 2017-08-04 2018-12-04 Braintree Laboratories, Inc. Solid oral sulfate salt formulations for cleaning a colon and methods of using same
CA3199266A1 (en) * 2020-10-26 2022-05-05 Braintree Laboratories, Inc. Sulfate salt formulations for colon cleansing
CN116509809B (zh) * 2023-04-19 2024-12-03 山东齐都药业有限公司 复方硫酸钠片剂及其制备方法与应用
US12239659B2 (en) 2023-06-15 2025-03-04 Braintree Laboratories, Inc. Methods of administering safe colon cleansing compositions

Family Cites Families (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3873694A (en) 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
JPS5438167B2 (lt) 1974-04-27 1979-11-19
JPS5562012A (en) 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2058565B (en) 1979-09-21 1983-12-07 Leo Pharm Prod Ltd Layer tablets
NZ198241A (en) 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
DE3134591A1 (de) 1981-09-01 1983-03-10 Bayer Ag, 5090 Leverkusen Neue arzneimittelpraeparationen fuer glykosidhydrolasen-inhibitoren
JPS5839618A (ja) 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
DE3266580D1 (en) 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
JPS59101423A (ja) 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
JPS6097919A (ja) 1983-11-01 1985-05-31 Furointo Sangyo Kk 圧縮成形用賦形剤の製造方法
NL8400911A (nl) 1984-03-22 1985-10-16 Dagra Nv Werkwijze ter bereiding van een farmaceutische toedieningsvorm die tetracycline of doxycyclinezouten bevat.
EP0231356A1 (en) 1985-08-01 1987-08-12 Braintree Laboratories, Inc. Low-sodium laxative and lavage formulation
US4753801A (en) 1985-10-25 1988-06-28 Eli Lilly And Company Sustained release tablets
ES2061623T3 (es) * 1987-03-02 1994-12-16 Brocades Pharma Bv Procedimiento para la obtencion de una composicion farmaceutica y un granulado farmaceutico.
IL86859A (en) 1987-07-10 1991-12-15 E Z Em Inc Aqueous cathartic solution containing inorganic salts
NO168563C (no) 1987-09-28 1992-03-11 Collett Marwell Hauge As Anvendelse av en organoleptisk akseptabel blanding av magnesiumsalter som mineraladditiv
US4837030A (en) 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
JPH0194937A (ja) * 1987-10-06 1989-04-13 Yokohama Yushi Kogyo Kk 微粉状ミネラル類の被覆物の製造方法
US5211958A (en) 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
US5274001A (en) 1987-12-24 1993-12-28 Borody Thomas J Orthostatic lavage solutions
WO1989009604A1 (en) 1988-04-05 1989-10-19 Dale Driver Dietary mineral sulfur supplement
JPH0816061B2 (ja) 1988-07-13 1996-02-21 森下ルセル株式会社 腸管洗浄液用組成物と腸管洗浄液
IT1229568B (it) 1989-04-17 1991-09-04 Giuliani Spa Composizione farmaceutica per uso orale adatta all'impiego nel lavaggio gastro intestinale, in particolare per uso diagnostico, oppure come lassativo catartico.
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
KR100278875B1 (ko) 1992-03-11 2001-01-15 데이비드 엠 모이어 과립화된 염기를 함유하는 실륨 음료 혼합 조성물
JPH08505609A (ja) 1992-11-24 1996-06-18 ブロック・ドラッグ・カンパニー・インク 胃腸洗浄用薬剤組成物
CA2241445C (en) 1996-05-08 2001-07-31 Craig A. Aronchick Non-aqueous colonic purgative formulations
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5498425A (en) 1995-03-17 1996-03-12 Block Drug Company, Inc. Phosphosoda buffered saline laxative
US5710183A (en) 1995-07-14 1998-01-20 Halow; George M. Laxative/antidiarrheal composition comprising polyethylene glycol and fiber bulking agent
AUPN634595A0 (en) 1995-11-03 1995-11-30 Borody, Thomas Julius Improved method for colonic evacuation
US6162464A (en) 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
DE69816060T2 (de) 1997-04-18 2004-04-22 Janssen Pharmaceutica N.V. Verwendung von 5ht3 antagonisten zum fördern der darmspülung
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
US6974590B2 (en) 1998-03-27 2005-12-13 Cima Labs Inc. Sublingual buccal effervescent
US6350470B1 (en) 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP2002528483A (ja) 1998-10-30 2002-09-03 マクニール−ピーピーシー・インコーポレイテッド 顆粒状で自由流動性の薬剤組成物、およびその経口投与のためのストロー状の投与形態
US6645481B1 (en) 2000-09-28 2003-11-11 Braintree Laboratories, Inc. Method of achieving overnight laxation and control of bowel function
US6887492B2 (en) 2000-12-14 2005-05-03 Leiner Health Services Corp. Magnesium plus interactive agent delivery
AUPR590701A0 (en) 2001-06-25 2001-07-19 Colocaps Pty Ltd Laxative preparation
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
US6946149B2 (en) 2002-04-30 2005-09-20 Braintree Laboratories, Inc. Salt solution for colon cleansing
US20040071779A1 (en) 2002-10-09 2004-04-15 Keiser Dale Arthur Gelled laxative compositions
US7291324B2 (en) 2002-10-22 2007-11-06 Braintree Laboratories Inc. Method of bowel cleansing
GB0224909D0 (en) 2002-10-25 2002-12-04 Norgine Europe Bv Colon cleansing compositions
JP2007525476A (ja) 2003-07-09 2007-09-06 ブレーントリー ラボラトリーズ インコーポレーティッド 緩下薬を用いた過敏性腸症候群の治療法
US7687075B2 (en) 2003-11-19 2010-03-30 Salix Pharmaceuticals, Ltd. Colonic purgative composition with soluble binding agent
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
ATE476180T1 (de) 2004-06-04 2010-08-15 Braintree Lab Verfahren zur darmreinigung
WO2007013093A2 (en) 2005-04-01 2007-02-01 Shiv Prakash Laxative formulation containing a triphala extract
WO2006118562A1 (en) 2005-04-29 2006-11-09 Inkine Pharmaceutical Company, Inc. Purgative composition and uses thereof
EP1877039A4 (en) 2005-05-06 2010-08-18 Salix Pharmaceuticals Inc Polyethylene glycol GUT CLEANING COMPOSITION
US20070087056A1 (en) 2005-08-09 2007-04-19 Claudia Guthmann Pharmaceutical form with sustained pH-independent active ingredient release for active ingredients having strong pH-dependent solubility
US20070082061A1 (en) 2005-10-07 2007-04-12 Nelson Ayala Reduction of saltiness with sweeteners
JP2009521994A (ja) 2005-12-29 2009-06-11 ブレーントリー ラボラトリーズ インコーポレーティッド 仮想結腸内視鏡検査を目的として結腸を準備するための、浸透圧性緩下薬および刺激性緩下薬を含むキット
US8067033B2 (en) * 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
US7998510B2 (en) 2006-08-17 2011-08-16 C. B. Fleet Company, Inc. Low dose colonic cleansing system
WO2008141368A1 (en) 2007-05-17 2008-11-27 David Lubowski Combination laxative compositions comprising a colonic stimulant and a bulking laxative
CN101938994A (zh) 2007-10-17 2011-01-05 托马斯杰弗逊大学 肠道催泻剂及其用途
CA2712341A1 (en) 2008-01-16 2009-07-23 Braintree Laboratories, Inc. Sulfate salt prophylaxis and therapies
US20090258090A1 (en) 2008-04-11 2009-10-15 Braintree Laboratories, Inc. Colon cleansing solution
PT2294012E (pt) 2008-05-07 2014-10-15 Salix Pharmaceuticals Ltd Administração de um agente de limpeza intestinal e de um antibiótico para o tratamento de doença intestinal
US20100255122A1 (en) 2009-04-02 2010-10-07 Garren Mary L Edible gelatin bowel preparation and bowel cleansing method
EP2421373B1 (en) 2009-04-21 2019-09-18 Dale R. Bachwich Colon lavage system
US20100285164A1 (en) * 2009-05-11 2010-11-11 Jrs Pharma Orally Disintegrating Excipient
GB0912487D0 (en) 2009-07-17 2009-08-26 Norgine Bv Improvements in and relating to colon cleansing compositions
GB0913295D0 (en) 2009-07-30 2009-09-02 Norgine Bv Improvements in and relating to pharmaceutical compositions
US20130121916A1 (en) 2010-03-10 2013-05-16 Sergio Baroni Compositions for Colon Lavage and Methods of Making and Using Same
CA2795977A1 (en) 2010-03-12 2011-09-15 Scott Cordray Method of treatment
JP5665372B2 (ja) * 2010-06-02 2015-02-04 旭化成ケミカルズ株式会社 速崩壊性固形製剤
US20130189377A1 (en) 2010-07-27 2013-07-25 Norgine Bv Compositions
EP2635264B8 (en) 2010-11-04 2018-07-18 Norgine B.V. Formulations comprising polyethylene glycol
DK2651415T3 (da) 2010-12-13 2020-11-30 Rite Prep Pty Ltd Mave- og tyktarmsformuleringer og fremgangsmåder til fremstilling og brug af dem
CN103282051A (zh) * 2010-12-28 2013-09-04 大鹏药品工业株式会社 口腔内崩解片剂
MX346936B (es) 2011-01-28 2017-04-05 A Shaver William Metodo, composiciones y empaque para limpieza del intestino.
PL2862566T3 (pl) 2011-01-31 2022-06-20 Norgine Healthcare B.V. Ulepszenia w i odnoszące się do kompozycji
TWI535461B (zh) 2011-03-11 2016-06-01 諾金私人有限公司 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法
PL2696690T3 (pl) 2011-04-15 2018-03-30 Braintree Laboratories, Inc. Sole siarczanowe jako środek poprawiający czas przejścia
US8778907B2 (en) 2011-04-27 2014-07-15 Cumberland Pharmaceuticals Lactulose for bowel evacuation
US20140235730A1 (en) 2011-09-23 2014-08-21 Gavis Pharmaceuticals, Llc Solid, edible, chewable laxative composition
AU2012327212B2 (en) 2011-10-27 2016-05-12 Rite-Prep Pty Ltd Electrolyte purgatives
US9149493B2 (en) 2011-11-28 2015-10-06 Alfa Wassermann Spa Compositions for bowel cleansing and use thereof
CN104936581A (zh) 2012-08-29 2015-09-23 萨利克斯药品有限公司 用于治疗便秘和相关胃肠道疾病和疾病状态的泻药组合物和方法
EP2895163B1 (en) 2012-09-11 2019-03-06 Norgine BV Compositions comprising peg and ascorbate
US20140087007A1 (en) 2012-09-27 2014-03-27 Braintree Laboratories, Inc. Bowel cleansing preparations
PL2968174T3 (pl) 2013-03-15 2020-05-18 Braintree Laboratories, Inc. Tabletki doustne kompozycji farmaceutycznej soli siarczanowych o podwójnym zastosowaniu i sposoby ich zastosowania

Also Published As

Publication number Publication date
CN105142617A (zh) 2015-12-09
CN108904462A (zh) 2018-11-30
PE20151543A1 (es) 2015-11-29
DK2968174T3 (da) 2019-12-16
HRP20192227T1 (hr) 2020-02-21
PL2968174T3 (pl) 2020-05-18
SI2968174T1 (sl) 2020-02-28
JP2019023244A (ja) 2019-02-14
EP2968174A1 (en) 2016-01-20
WO2014144407A1 (en) 2014-09-18
JP6724114B2 (ja) 2020-07-15
EA201992382A2 (ru) 2020-02-28
AU2019201511A1 (en) 2019-03-28
EA201992382A3 (ru) 2020-05-31
JP2016514677A (ja) 2016-05-23
PT2968174T (pt) 2020-01-15
BR112015019776A2 (pt) 2017-07-18
ME03656B (me) 2020-07-20
AU2014227598B2 (en) 2018-12-06
JP6441890B2 (ja) 2018-12-19
CA2903283C (en) 2023-09-05
CA2903283A1 (en) 2014-09-18
IL241367A0 (en) 2015-11-30
US20160030473A1 (en) 2016-02-04
MX377525B (es) 2025-03-10
HK1214519A1 (zh) 2016-07-29
SMT201900716T1 (it) 2020-01-14
EP3563838A1 (en) 2019-11-06
US9919007B2 (en) 2018-03-20
MX2015012109A (es) 2016-04-15
EA034234B1 (ru) 2020-01-20
US20180207200A1 (en) 2018-07-26
ES2764462T3 (es) 2020-06-03
HUE046754T2 (hu) 2020-03-30
CY1122387T1 (el) 2020-11-25
AU2014227598A1 (en) 2015-08-27
WO2014144407A8 (en) 2014-11-20
RS59667B1 (sr) 2020-01-31
CN105142617B (zh) 2018-08-03
EA201591568A1 (ru) 2015-12-30
AU2020213378A1 (en) 2020-08-27
EP2968174B1 (en) 2019-10-16

Similar Documents

Publication Publication Date Title
LTPA2018511I1 (lt) Policikliniai karbamoilpiridino junginiai ir jų farmacinis panaudojimas
LT2986304T (lt) Farmacinė kompozicija, gydymo būdai ir jų panaudojimas
LT3043785T (lt) R-ketamino ir jo druskų vartojimas kaip vaistų
IL243608A0 (en) Substances with antiviral activity, preparations containing them and their uses
PT3030262T (pt) Composição farmacêutica de associação
LT2968174T (lt) Dviem būdais vartojama geriamoji sulfato druskų tablečių farmacinė kompozicija ir jos naudojimo būdai
LT3121164T (lt) Sulfamoilpirolamido dariniai ir jų panaudojimas kaip vaistų hepatito b gydymui
IL240290B (en) History of pyridazinone-amide and pharmaceutical preparations containing them
BR112016003229A2 (pt) Composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
LT2968172T (lt) Stabilizuota modifikuoto atpalaidavimo vitamino d kompozicija ir jos įvedimo būdas
DK3020408T3 (da) Traditionel kinesisk medicinsammensætning og fremstilling og anvendelse heraf
IL237421A0 (en) Topical compositions and methods of use
PT2859896T (pt) Composições farmacêuticas para o tratamento de distúrbios musculares
EP3049370A4 (en) Use of sulfur and selenium compounds as precursors to nanostructured materials
FI20125888A7 (fi) Anisomelihapon farmaseuttiset koostumukset ja niiden käyttö
IL241513A0 (en) History of piperazine, their preparation and pharmaceutical preparations containing them
PL2991618T3 (pl) Stabilna kompozycja farmaceutyczna o wysokim stężeniu lewoleukoworyny
IL245771A0 (en) Synthesis and compositions of porphyrin compounds
IL240292A0 (en) History of quinazoline and pharmaceutical preparations containing them
TWI562776B (en) Pharmaceutical composition and uses thereof
PT3011972T (pt) Composição medicinal para promover síntese de protoporfirina ix
SG11201602826VA (en) Icotinib-containing topical skin pharmaceutical compositions and uses thereof
EP2986112A4 (en) PREPARATION AND USE OF FULVINIC ACID DERIVATIVES
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
PL3236938T3 (pl) Doustne miejscowe wodne kompozycje farmaceutyczne flurbiprofenu i dekspantenolu